Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 12 studies | 66% ± 23% | |
epithelial cell | 8 studies | 58% ± 27% | |
enterocyte | 6 studies | 63% ± 13% | |
intestinal crypt stem cell | 6 studies | 58% ± 32% | |
enteroendocrine cell | 5 studies | 44% ± 26% | |
transit amplifying cell | 5 studies | 60% ± 31% | |
renal alpha-intercalated cell | 4 studies | 51% ± 6% | |
progenitor cell | 4 studies | 66% ± 24% | |
paneth cell | 4 studies | 75% ± 19% | |
acinar cell | 4 studies | 95% ± 6% | |
abnormal cell | 3 studies | 35% ± 18% | |
luminal cell of prostate epithelium | 3 studies | 26% ± 1% | |
secretory cell | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 248060.30 | 328 / 328 | 86% | 1572.78 | 153 / 178 |
stomach | 89% | 14357.70 | 318 / 359 | 86% | 514.81 | 246 / 286 |
intestine | 67% | 1953.55 | 649 / 966 | 85% | 405.57 | 447 / 527 |
bladder | 90% | 4451.62 | 19 / 21 | 61% | 866.09 | 305 / 504 |
liver | 79% | 5392.41 | 178 / 226 | 58% | 661.77 | 234 / 406 |
kidney | 97% | 2230.75 | 86 / 89 | 7% | 45.18 | 59 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 1736.25 | 1 / 1 |
lung | 34% | 49.76 | 196 / 578 | 32% | 283.51 | 368 / 1155 |
skin | 59% | 57.45 | 1065 / 1809 | 0% | 0.14 | 1 / 472 |
prostate | 45% | 81.36 | 111 / 245 | 12% | 62.01 | 59 / 502 |
esophagus | 15% | 36.73 | 212 / 1445 | 39% | 207.36 | 71 / 183 |
blood vessel | 49% | 140.18 | 654 / 1335 | 0% | 0 | 0 / 0 |
uterus | 15% | 13.09 | 25 / 170 | 9% | 92.77 | 43 / 459 |
breast | 23% | 70.92 | 107 / 459 | 0% | 0.08 | 1 / 1118 |
spleen | 22% | 36.93 | 54 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 21% | 17.76 | 54 / 258 | 0% | 0.98 | 1 / 230 |
heart | 20% | 27.33 | 173 / 861 | 0% | 0 | 0 / 0 |
ovary | 17% | 16.84 | 30 / 180 | 1% | 18.32 | 3 / 430 |
adipose | 15% | 94.84 | 175 / 1204 | 0% | 0 | 0 / 0 |
thymus | 11% | 13.18 | 75 / 653 | 0% | 0 | 0 / 605 |
muscle | 9% | 8.97 | 72 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 9% | 35.05 | 79 / 929 | 0% | 0 | 0 / 0 |
brain | 6% | 9.10 | 153 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0050732 | Biological process | negative regulation of peptidyl-tyrosine phosphorylation |
GO_0031667 | Biological process | response to nutrient levels |
GO_0090187 | Biological process | positive regulation of pancreatic juice secretion |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0060046 | Biological process | regulation of acrosome reaction |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0048240 | Biological process | sperm capacitation |
GO_2001256 | Biological process | regulation of store-operated calcium entry |
GO_0071375 | Biological process | cellular response to peptide hormone stimulus |
GO_0007263 | Biological process | nitric oxide mediated signal transduction |
GO_0010751 | Biological process | negative regulation of nitric oxide mediated signal transduction |
GO_0045471 | Biological process | response to ethanol |
GO_0090277 | Biological process | positive regulation of peptide hormone secretion |
GO_0090281 | Biological process | negative regulation of calcium ion import |
GO_0070062 | Cellular component | extracellular exosome |
GO_0004866 | Molecular function | endopeptidase inhibitor activity |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SPINK1 |
Protein name | Serine protease inhibitor Kazal-type 1 (Pancreatic secretory trypsin inhibitor) (Tumor-associated trypsin inhibitor) (TATI) Serine peptidase inhibitor Kazal type 1 Pancreatic secretory trypsin inhibitor |
Synonyms | PSTI |
Description | FUNCTION: Serine protease inhibitor which exhibits anti-trypsin activity . In the pancreas, protects against trypsin-catalyzed premature activation of zymogens (By similarity). .; FUNCTION: In the male reproductive tract, binds to sperm heads where it modulates sperm capacitance by inhibiting calcium uptake and nitrogen oxide (NO) production. . |
Accessions | ENST00000510027.2 D6RIU5 A2T2X6 P00995 A2T2X7 ENST00000296695.10 |